Biotech News
Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
ir.catalystbiosciences.com2026-05-06 15:21 EST
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today announced that management will present at the